Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
147,079,094
-
Total 13F shares
-
188,211,491
-
Share change
-
+15,121,567
-
Total reported value
-
$51,456,575,196
-
Put/Call ratio
-
122%
-
Price per share
-
$273.42
-
Number of holders
-
1,016
-
Value change
-
+$4,118,247,453
-
Number of buys
-
465
-
Number of sells
-
475
Institutional Holders of BIOGEN INC. - COMMON STOCK (BIIB) as of Q1 2017
As of 31 Mar 2017,
BIOGEN INC. - COMMON STOCK (BIIB) was held by
1,016 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
188,211,491 shares.
The largest 10 holders included
BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Invesco Ltd., and JPMORGAN CHASE & CO.
This page lists
1,017
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.